These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

125 related articles for article (PubMed ID: 12972492)

  • 1. Definition of discontinuation of anti-tumour necrosis factor therapy in rheumatoid arthritis: a preliminary proposal.
    Braun J; Sieper J; van der Heijde D
    Ann Rheum Dis; 2003 Oct; 62(10):1023-4. PubMed ID: 12972492
    [No Abstract]   [Full Text] [Related]  

  • 2. BSR and BHPR rheumatoid arthritis guidelines on safety of anti-TNF therapies.
    Ding T; Ledingham J; Luqmani R; Westlake S; Hyrich K; Lunt M; Kiely P; Bukhari M; Abernethy R; Bosworth A; Ostor A; Gadsby K; McKenna F; Finney D; Dixey J; Deighton C; ;
    Rheumatology (Oxford); 2010 Nov; 49(11):2217-9. PubMed ID: 20837498
    [No Abstract]   [Full Text] [Related]  

  • 3. Updating the British Society for Rheumatology guidelines for anti-tumour necrosis factor therapy in adult rheumatoid arthritis (again).
    Deighton CM; George E; Kiely PD; Ledingham J; Luqmani RA; Scott DG
    Rheumatology (Oxford); 2006 Jun; 45(6):649-52. PubMed ID: 16527881
    [No Abstract]   [Full Text] [Related]  

  • 4. Guidelines for initiation of anti-tumour necrosis factor therapy in rheumatoid arthritis: similarities and differences across Europe.
    Emery P; Van Vollenhoven R; Ostergaard M; Choy E; Combe B; Graninger W; Krueger K; Matucci-Cerinic M; Navarro F; van Riel P; Settas L; Steinfeld S
    Ann Rheum Dis; 2009 Apr; 68(4):456-9. PubMed ID: 19286904
    [No Abstract]   [Full Text] [Related]  

  • 5. [Proposal for anti-TNFalpha therapy in adult patients with rheumatoid arthritis].
    Curković B; Babić-Naglić D; Morović-Vergles J; Anić B; Grazio S
    Reumatizam; 2007; 54(1):16-9. PubMed ID: 18450272
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Proposal for anti-TNFalpha therapy in adult patients with rheumatoid arthritis].
    Curković B; Babić-Naglić D; Morović-Vergles J; Anić B; Grazio S
    Reumatizam; 2008; 55(1):22-5. PubMed ID: 19024266
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Septic arthritis caused by Actinobacillus ureae in a patient with rheumatoid arthritis receiving anti-tumor necrosis factor-alpha therapy.
    Kaur PP; Derk CT; Chatterji M; Dehoratius RJ
    J Rheumatol; 2004 Aug; 31(8):1663-5. PubMed ID: 15290751
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Periodontitis and etanercept discontinuation risk in anti-tumor necrosis factor-naive rheumatoid arthritis patients: a nationwide population-based cohort study.
    Chen HH; Chen DY; Lai KL; Chen YM; Chou YJ; Chou P; Lin CH; Huang N
    J Clin Rheumatol; 2013 Dec; 19(8):432-8. PubMed ID: 24263145
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Etanercept treatment of rheumatoid arthritis in the "real world".
    Smith MD
    Ann Rheum Dis; 2003 Jan; 62(1):95-6; author reply 96. PubMed ID: 12480688
    [No Abstract]   [Full Text] [Related]  

  • 10. [Basic therapeutic and immunosuppressive drugs in rheumatoid arthritis. No fear of "heavy weapons"].
    Krüger K
    MMW Fortschr Med; 2002 Aug; 144(33-34):25-30. PubMed ID: 12380140
    [No Abstract]   [Full Text] [Related]  

  • 11. The new era in the treatment of rheumatoid arthritis.
    Putterman C
    Am J Orthop (Belle Mead NJ); 2007 Jul; 36(7 Suppl):2-4. PubMed ID: 17694188
    [No Abstract]   [Full Text] [Related]  

  • 12. Etanercept is effective in patients with rheumatoid arthritis with no response to infliximab therapy.
    Gómez-Puerta JA; Sanmartí R; Rodríguez-Cros JR; Cañete JD
    Ann Rheum Dis; 2004 Jul; 63(7):896. PubMed ID: 15194598
    [No Abstract]   [Full Text] [Related]  

  • 13. [New drug treatments for rheumatoid arthritis].
    Nordström DC; Konttinen YT
    Duodecim; 2000; 116(11):1221-5. PubMed ID: 11989008
    [No Abstract]   [Full Text] [Related]  

  • 14. [Anti-TNF-alpha antibody].
    Amano K; Takeuchi T
    Nihon Rinsho; 2005 May; 63 Suppl 5():734-40. PubMed ID: 15954438
    [No Abstract]   [Full Text] [Related]  

  • 15. Abatacept: new drug. Rheumatoid arthritis: after failure of TNF alpha antagonists and rituximab.
    Prescrire Int; 2008 Dec; 17(98):232. PubMed ID: 19422143
    [No Abstract]   [Full Text] [Related]  

  • 16. Paraplegia in a patient receiving anti-tumor necrosis factor therapy for rheumatoid arthritis: comment on the article by Mohan et al.
    van der Laken CJ; Lems WF; van Soesbergen RM; van der Sande JJ; Dijkmans BA
    Arthritis Rheum; 2003 Jan; 48(1):269-70. PubMed ID: 12528130
    [No Abstract]   [Full Text] [Related]  

  • 17. Total cholesterol, lipoprotein, and triglyceride levels in tumor necrosis factor inhibitor-treated patients with psoriasis, psoriatic arthritis, or rheumatoid arthritis.
    Wu JJ; Rowan CG; Bebchuk JD; Anthony MS
    Int J Dermatol; 2015 Oct; 54(10):e442-5. PubMed ID: 26234307
    [No Abstract]   [Full Text] [Related]  

  • 18. New tumour necrosis factor inhibitors for rheumatoid arthritis: are there benefits from extending choice?
    Scott DL; Cope A
    Ann Rheum Dis; 2009 Jun; 68(6):767-9. PubMed ID: 19435722
    [No Abstract]   [Full Text] [Related]  

  • 19. Necrobiosis lipoidica occurring in a patient with rheumatoid arthritis on concurrent tumor necrosis factor-α inhibitor therapy.
    Chung CG; Rosengrant A; Helm KF; Shupp DL
    Int J Dermatol; 2015 Nov; 54(11):1294-6. PubMed ID: 24697547
    [No Abstract]   [Full Text] [Related]  

  • 20. [Current therapeutic strategy for rheumatoid arthritis].
    Wollenhaupt J; Alten R; Burkhardt H; Edelmann E; Gromnica-Ihle E; Krause A; Krüger K; Manger B; Lorenz H; Müller-Ladner U; Nüsslein H; Pott HG; Tony H; Schneider M
    MMW Fortschr Med; 2006 Oct; 148(42):38-42; quiz 43. PubMed ID: 17621798
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.